Celldex Therapeutics, Inc.
DE ˙ DB ˙ US15117B2025
€ 25,28 ↑0.78 (3.18%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:TCE2 / Celldex Therapeutics, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership33,436 shares
Latest Disclosed Value $ 1,060,590
Creative Planning ownership in TCE2 / Celldex Therapeutics, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 33,436 shares of Celldex Therapeutics, Inc. (DE:TCE2) valued at $855,962 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,404 shares of Celldex Therapeutics, Inc.. This represents a change in shares of 6.47% during the quarter. The current value of the position is $845,262 USD.

Creative Planning has a history of taking positions in derivatives of the underlying security (TCE2) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:TCE2 / Celldex Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 33,436 2,032 6.47 1,061 24.41 0.0007
2026-02-17 2025-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 31,404 -1,866 -5.61 853 -0.93 0.0006
2025-11-14 2025-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 33,270 3,368 11.26 861 41.45 0.0007
2025-08-08 2025-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 29,902 6,233 26.33 609 41.72 0.0005
2025-05-15 2025-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 23,669 3,815 19.22 430 -14.37 0.0004
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,854 5,035 33.98 502 -0.40 0.0005
2024-10-11 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 14,819 14,819 504 0.0005
2024-08-15 2024-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -4,944 -100.00 0 -100.00
2024-05-13 2024-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 4,944 -18,261 -78.69 207 -77.50 0.0002
2024-02-14 2023-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 23,205 2,383 11.44 920 60.56 0.0017
2023-11-16 2023-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 20,822 550 2.71 573 -16.59 0.0008
2023-07-21 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 20,272 13 0.06 688 -5.63 0.0009
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 20,259 111 0.55 729 -18.84 0.0010
2023-02-10 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 20,148 343 1.73 898 61.04 0.0014
2022-11-03 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,805 53 0.27 557 4.50 0.0010
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,752 44 0.22 533 -20.57 0.0009
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,708 0 0.00 671 -11.94 0.0010
2022-02-11 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,708 -4,400 -18.25 762 -41.47 0.0012
2021-11-10 2021-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 24,108 0 0.00 1,302 61.54 0.0023
2021-08-04 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 24,108 -39 -0.16 806 62.17 0.0014
2021-04-30 2021-03-31 13F CreativePlanning COM NEW 15117B202 24,147 -11,000 -31.30 497 -19.32 0.0010
2021-01-29 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 35,147 -200 -0.57 616 17.56 0.0014
2020-11-05 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 35,347 0 0.00 524 13.91 0.0014
2020-07-23 2020-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 35,347 23,200 190.99 460 2,200.00 0.0013
2020-05-05 2020-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 12,147 0 0.00 20 -25.93 0.0001
2020-01-30 2019-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 12,147 -419 -3.33 27 0.00 0.0001
2019-11-01 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 12,566 53 0.42 27 -20.59 0.0001
2019-07-26 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 12,513 300 2.46 34 -43.33 0.0001
2019-04-24 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 12,213 -13,993 -53.40 60 1,100.00 0.0002
2019-02-12 2018-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 26,206 4,830 22.60 5 -50.00 0.0000
2019-02-01 2018-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 26,206 4,830 5
2018-10-25 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 21,376 6,140 40.30 10 25.00 0.0000
2018-07-20 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 15,236 -93,980 -86.05 8 -96.85 0.0000
2018-04-18 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 109,216 19,930 22.32 254 0.00 0.0010
2018-01-17 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 89,286 8,000 9.84 254 9.48 0.0011
2017-10-17 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 81,286 1,150 1.44 232 17.17 0.0011
2017-07-12 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 80,136 8,716 12.20 198 -23.26 0.0010
2017-04-07 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 71,420 4,084 6.07 258 8.40 0.0014
2017-01-09 2016-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 67,336 11,990 21.66 238 6.25 0.0014
2016-10-12 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 55,346 50,180 971.35 224 873.91 0.0014
2016-07-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 5,166 400 8.39 23 27.78 0.0002
2016-04-08 2016-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 4,766 -9,557 -66.72 18 -92.00 0.0001
2016-01-11 2015-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 14,323 8,700 154.72 225 281.36 0.0019
2015-10-09 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 5,623 5,623 0.00 59 0.0005
2015-07-09 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -3,506 -100.00 0 -100.00
2015-04-13 2015-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 3,506 3,506 0.00 98 0.0009
2015-01-29 2014-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -2,128 -100.00 0 -100.00
2014-10-10 2014-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,128 -16,146 -88.36 28 -90.60 0.0003
2014-08-20 2014-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 18,274 18,200 24,594.59 298 29,700.00 0.0039
2014-04-11 2014-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 74 0 0.00 1 -50.00 0.0000
2014-01-06 2013-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 74 20 37.04 2 0.00 0.0000
2013-10-10 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 54 54 2 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-10-10 2014-09-30 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-20 2014-06-30 13F CELLDEX THERAPEUTICS INC COM Call 14,000 34 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-11-16 2023-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-07-21 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 9,000 0.00 5 -71.43 n/a n/a n/a
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 9,000 -54.08 15 1,300.00 n/a n/a n/a
2023-02-10 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 19,600 0.00 2 -97.96 n/a n/a n/a
2022-11-03 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 19,600 49 n/a n/a n/a
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 19,600 30 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.